416 related articles for article (PubMed ID: 16097843)
21. Economic burden of Parkinson's disease in Singapore.
Zhao YJ; Tan LC; Li SC; Au WL; Seah SH; Lau PN; Luo N; Wee HL
Eur J Neurol; 2011 Mar; 18(3):519-26. PubMed ID: 20840378
[TBL] [Abstract][Full Text] [Related]
22. [Disability Pension and Productivity Loss in Schizophrenia - An Empirical Analysis of the Financial Burden in Germany].
Kortmann LM; Müller D; Simic D; Civello D; Stock S
Psychiatr Prax; 2017 Mar; 44(2):93-98. PubMed ID: 27399592
[No Abstract] [Full Text] [Related]
23. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
[TBL] [Abstract][Full Text] [Related]
24. [Economic rehabilitation management among patients with chronic low back pain].
Seitz R; Schweikert B; Jacobi E; Tschirdewahn B; Leidl R
Schmerz; 2001 Dec; 15(6):448-52. PubMed ID: 11793150
[TBL] [Abstract][Full Text] [Related]
25. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
[TBL] [Abstract][Full Text] [Related]
26. [Prospective study of the direct and indirect costs of idiopathic Parkinson's disease].
Dengler I; Leukel N; Meuser T; Jost WH
Nervenarzt; 2006 Oct; 77(10):1204-9. PubMed ID: 17004081
[TBL] [Abstract][Full Text] [Related]
27. Cost-of-illness of patients with lymphoedema.
Gutknecht M; Herberger K; Klose K; Purwins S; Dietz D; Blome C; Augustin M
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1930-1935. PubMed ID: 28662302
[TBL] [Abstract][Full Text] [Related]
28. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease.
Valldeoriola F; Morsi O; Tolosa E; Rumià J; Martí MJ; Martínez-Martín P
Mov Disord; 2007 Nov; 22(15):2183-91. PubMed ID: 17724747
[TBL] [Abstract][Full Text] [Related]
29. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
Chuvarayan Y; Finger RP; Köberlein-Neu J
Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
[TBL] [Abstract][Full Text] [Related]
30. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
[TBL] [Abstract][Full Text] [Related]
31. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
[TBL] [Abstract][Full Text] [Related]
32. Costs of drug treatment in Parkinson's disease.
Dodel RC; Eggert KM; Singer MS; Eichhorn TE; Pogarell O; Oertel WH
Mov Disord; 1998 Mar; 13(2):249-54. PubMed ID: 9539337
[TBL] [Abstract][Full Text] [Related]
33. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States.
Martinez-Martin P; Macaulay D; Jalundhwala YJ; Mu F; Ohashi E; Marshall T; Sail K
Mov Disord; 2019 Feb; 34(2):236-245. PubMed ID: 30589953
[TBL] [Abstract][Full Text] [Related]
34. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
35. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
[TBL] [Abstract][Full Text] [Related]
36. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.
Ehlken B; Ihorst G; Lippert B; Rohwedder A; Petersen G; Schumacher M; Forster J;
Eur J Pediatr; 2005 Oct; 164(10):607-15. PubMed ID: 15965766
[TBL] [Abstract][Full Text] [Related]
37. Cost-of-illness of psoriasis - results of a German cross-sectional study.
Jungen D; Augustin M; Langenbruch A; Zander N; Reich K; Strömer K; Thaci D; Purwins S; Radtke M; Gutknecht M
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):174-180. PubMed ID: 28857297
[TBL] [Abstract][Full Text] [Related]
38. Economic burden in a German cohort of patients with multiple sclerosis.
Reese JP; John A; Wienemann G; Wellek A; Sommer N; Tackenberg B; Balzer-Geldsetzer M; Dodel R
Eur Neurol; 2011; 66(6):311-21. PubMed ID: 22086151
[TBL] [Abstract][Full Text] [Related]
39. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study].
Marcellusi A; Viti R; Incorvaia C; Mennini FS
Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978
[TBL] [Abstract][Full Text] [Related]
40. Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care.
Mohr N; Naatz M; Zeervi L; Langenbruch A; Bieber T; Werfel T; Wollenberg A; Augustin M
J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):1346-1356. PubMed ID: 33651457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
